Media contact

Lucy Carroll
UNSW External Communications
9385 8732, 0402 005 319
l.carroll@unsw.edu.au

Programs that provide same-day testing for infectious disease, better health care for children with neurodevelopmental problems and the development of cancer treatments that target copper in tumours are some of the UNSW projects that will share more than $25 million in NHMRC funding.

In his latest funding announcement, Minister for Health Greg Hunt committed $192 million in NHMRC grants for 320 projects across Australia on medical and scientific research into research projects to improve the health of Australian patients through new treatments and support, tackling areas of obesity, mental health and cardiovascular disease.

More than $25 million was allocated to UNSW researchers across Career Development Fellowships, Early Career Fellowships, Research and Practitioner Fellowships, Partnership Grants and Centre for Research Excellence funding.

Professor Nicholas Fisk, UNSW Deputy Vice-Chancellor (Research), congratulated the recipients.

“UNSW researchers have been recognised for their exceptional contribution to health and medical research in Australia and their ongoing commitment to overcoming major health challenges though cutting edge research to improve health care,” Professor Fisk said. “UNSW did particularly well in the flagship Centres of Research Excellence, with the most (three out of 16) awarded nationally. Our researchers received a total of $25.5 million, the third-highest in the Group of Eight.”

Professors Rebecca Guy and John Kaldor from The Kirby Institute, based at UNSW, will receive $5 million in funding to improve the control of infectious diseases in the Asia-Pacific region.

Professor Guy, Head of the Surveillance Evaluation and Research Program at the Kirby Institute, will lead a Centre for Research Excellence with collaborators from UNSW and other research organisations developing immediate point of care tests for infectious diseases of global importance, including HIV, hepatitis C, tuberculosis, HPV and STIs. It will take place across 300 primary health care services in Australia, Papua New Guinea, Vietnam and Indonesia.

Rebecca Guy 1

The Kirby Institute's Rebecca Guy.

“Our previous work in this area has shown that POC testing in primary care works to improve infectious disease diagnosis in remote Aboriginal communities in Australia,” said Professor Guy. “This project will break down barriers to treatment access, ultimately leading to major reductions in the associated illnesses, and improvements in the overall health of these communities.”

Professor Kaldor, Head of the Kirby’s Public Health Interventions Research Group, received funding to establish the Australian Centre for the Control and Elimination of Neglected Tropical Diseases. The Centre will accelerate the control and the elimination of key neglected tropical diseases, focussing on seven countries in the Asia-Pacific region.

Professor Helen Christensen, Director at the Black Dog Institute and a UNSW professor of mental health, will receive almost $2.5 million to establish the Centre of Research Excellence in Suicide Prevention: CRESP II. The Centre will build on the substantive body of work undertaken during the CRE’s first iteration, in particular the development of Australia’s first systems approach to suicide prevention. Phase II will focus on taking findings to scale, leveraging technology to ensure maximum impact in the face of Australia’s vast geographical landscape.

helen christensen_23q0079.jpg

Scientia Professor Helen Christensen. Photo: Quentin Jones

UNSW early and mid-career researchers were also recipients of major grants, with nine Early Career Fellowships and six Career Development Fellowships going to researchers in the faculties of Medicine, Science and Engineering.

Associate Professor Susan Woolfenden, from UNSW Medicine and Sydney Children's Hospital Randwick, received a Career Development Fellowship to establish a health inequities research program for children with neurodevelopmental problems ranging from language delay to cerebral palsy.

“Families with the least financial and social resources are most likely to have children with neurodevelopmental problems,” says Associate Professor Woolfenden. “They are also the least likely to receive services to diagnose and treat their children. This funding will support my work with children with neurodevelopmental problems from Indigenous, socioeconomically disadvantaged and culturally diverse communities, which has supported changes in policy and practice in NSW.”

Dr Orazio Vittorio from the Children's Cancer Institute at UNSW has received funding for targeting copper homeostasis in aggressive childhood tumours.

“My vision is to develop effective cancer treatments to target copper in tumours using sophisticated new approaches, with a better understanding of cancer biology. The aim of this fellowship is to make contributions to develop targeted drugs for improving survival and quality of life of neuroblastoma patients,” said Dr Vittorio.

Early Career Fellowship recipient Dr Nusrat Homaira will use funding for her project to improve health care delivery services for children with asthma through an enhanced influenza vaccination strategy.

“Influenza is the one of the main infectious causes of unscheduled hospital presentations in asthmatic children,” says Dr Homaira. “My study will examine the impact of a school-based influenza vaccine delivery service on improving influenza vaccine uptake and reducing health care utilisation in Australian children with asthma and potentially act as a model for other chronic lung conditions.”

A full list of grant recipients is available on the NHMRC website: www.nhmrc.gov.au

Other recipients include:

  • Doctor Alastair Stewart, Victor Chang Cardiac Research Institute, ATP synthase: Regulation, antibiotics and mitochondrial disease
  • Doctor Kang Liang, Faculty of Engineering, Vision for a versatile nanodevice for early-stage disease and cancer diagnostics
  • Associate Professor Gail Matthews, Career Development Fellowship for Strategies towards control and elimination of viral hepatitis
  • Associate Professor Nicola Newton, Faculty of Medicine and National Drug and Alcohol Research Centre, Optimising prevention of substance use and mental health problems
  • Doctor Nicholas Medland, The Kirby Institute, Elimination of HIV infection in vulnerable populations through rapid translation of research into treatment as prevention and pre-exposure Prophylaxis Programs and Clinical Practice
  • Doctor Beeke Wienert, Faculty of Science, Identifying novel pathways of red blood cell differentiation by CRISPR screening
  • Doctor Patricia Cullen, Faculty of Medicine, Setting health pathways for life: improving adolescent health trajectories
  • Doctor Marianne Martinello, The Kirby Institute, Hepatitis C treatment as prevention: Strategies to guide elimination in priority populations
  • Doctor Nusrat Homaira, Faculty of Medicine, Improving health care delivery services for children with asthma through an enhanced school-based influenza vaccination strategy
  • Doctor Andrea Schaffer, Centre for Big Data Research in Health, Evaluating population-level medicine policy interventions: generating high-quality evidence about intended and unintended consequences
  • Doctor Anna Palagyi, The George Institute for Global Health, A health systems approach for strengthening primary health care
  • Kathy Trieu, The George Institute for Global Health, Population strategies to achieve optimal intakes of sodium and potassium for the prevention of hypertension and cardiovascular disease
  • Doctor Louise Causer, The Kirby Institute, Maximising impact: scaling up new diagnostics for STI control
  • Professor Jane Butler, Neuroscience Research Australia, Respiratory motor impairment in health and disease, Preventing drug-related harms and progressing the elimination of HIV and viral hepatitis in people who inject drugs
  • Professor Lisa Maher, The Kirby Institute, Preventing drug-related harms and progressing the elimination of HIV and viral hepatitis in people who inject drugs
  • Professor John Kaldor, The Kirby Institute, Population health interventions to control infectious diseases and their consequences
  • Scientia Professor Katharina Gaus, Faculty of Medicine, T cell receptor (TCR) singalling efficiency
  • Professor Helen Christensen, Black Dog Institute, Landmark population trials in suicide prevention
  • Professor Richard Mattick, National Drug and Alcohol Research Centre, Alcohol, tobacco, illicit and prescribed drugs: observational studies and trials of treatment
  • Professor Guy Marks, Faculty of Medicine, A world that breathes more easily: research for improving global lung health
  • Professor Richard Lock, Children's Cancer Institute, Improving the treatment of childhood cancer
  • Professor Anthony Rodgers, The George Institute for Global Health, Improving outcomes for people with chronic diseases with better use of affordable medicines
  • Professor Basil Donovan, The Kirby Institute, Sexually transmissible infections: outcomes and interventions